WHAT IS YOUR DIAGNOSIS?
A six year, female neutered, Labrador Retriever was presented to the R(D)SVS Internal
Medicine Service for investigation of pyrexia. The dog had a recent history of coughing and
had been receiving treatment with antibiotics and fenbendazole prior to referral.
On clinical examination, the dog was quiet but alert with a body condition score of 6/9. The
heart rate was 100 bpm with no arrhythmia, murmur or pulse deficits. The respiratory rate
was 32 breaths/minute, with no adventitious lung sounds. Abdominal palpation and
peripheral lymph nodes were unremarkable and the rectal temperature was 39.6°C.
Routine hematology serum biochemistry and routine urine analysis were performed. Serum
biochemistry and urine results were unremarkable but the following haematology results
were obtained.
Parameter
Results
Reference Range
PCV
0.36
0.39-0.55l/l
WBC
0.33 x109/l
5.04-16.76 x109/l
Neutrophils
0.02 x109/l
2.95-11.6 x109/l
Lymphocytes
0.27 x109/l
1.05-5.1 x109/l
Monocytes
0.04 x109/l
0.6-1.2 x109/l
Eosinophils
0 x109/l
0.06-1.23 x109/l
Platelets
29 1012/l
300-500 x1012/l
Smear evaluation confirmed the thrombocytopenia. The few white cells present were
morphologically unremarkable. No significant red cell abnormalities were present.
1) What are your differential diagnoses for pancytopenia in this dog?
2) What other diagnostic evaluations would you perform?
3) How would you treat this dog pending definitive test results?
page 1 of 3 1. Differential diagnosis for pancytopenia
o
o
o
o
o
o
o
o
o
o
Oestrogen toxicity
Myelodysplasia
Idiopathic/immune-mediated disease targeting bone marrow myeloid precursors
Secondary to infections or neoplasia elsewhere in the body
Tick borne infections
Drug reactions
Myelophthisis secondary to bone marrow neoplasia
Bone marrow fibrosis
Septicemia/Salmonella infections
Parvovirus infection
In this case, the dog was well and cardiovascularly stable making septicemia unlikely. The
pyrexia may have been caused by infections or neoplastic diseases, although no clear
evidence of an inciting cause was present on physical examination. Recent medication
administration meant that drug toxicity was a possibility.
2. Further tests
The most useful test in a dog with pancytopenia with no obvious apparent course (e.g.
recent chemotherapy, evidence of sepsis) is to perform a bone marrow aspirate and core
biopsy. This allows many primary bone marrow diseases to be excluded. In addition,
thoracic radiographs and abdominal ultrasound scans were performed in this case to
investigate a potential underlying neoplastic cause. No abnormalities were apparent. In
house serology testing (IDEXX 4DX snap test) for tick borne disease including Anaplasma
phagocytophilum and Borrelia burgdorferi was performed to exclude tick-borne pathogens
as serological testing was negative.
Bone marrow biopsies and cytology revealed no dysplastic or neoplastic changes. Myeloid
precursors and megakaryocytes were lacking indicating a relatively poorly responsive for a
dog with neutropenia and thrombocytopenia. There was no evidence of bone marrow
fibrosis.
Based on an absence of evidence for infectious, neoplastic or autoimmune diseases, we
suspected the dog an acute toxic insult to her bone marrow. Bone marrow toxicity has been
reported in dogs treated with fenbendazole. Following drug cessation, encouraging
improvements were seen in the white blood cell population. In a case report of
fenbendazole toxicity (Gray et al. Bone Marrow Hypoplasia Associated With Fenbendazole
Administration in a Dog. Journal of the American Animal Hospital Association May 1, 2004
vol. 40 no. 3 224-229), similar pathological changes are reported. The pancytopenia in this
case gradually resolved within two weeks of discontinuation of fenbendazole treatment.
3. Treatment pending definitive diagnosis
page 2 of 3 Considering her pyrexia and profound neutropenia, the dog was treated in hospital with
20mg/kg q8hours with IV potentiated amoxicillin for potential secondary bacterial
infection. Prophylactic antibiotics are advisable in dogs with a total neutrophil count of <
1 x109/l.
Outcome
A haematology profile taken a week later showed a significant improvement with
platelet numbers of 77 x109/l (ref 200-500 x109/l) and neutrophil count of 1.97x109/l (ref
3.6-12.0 x109/l). All other cells lines were within normal reference intervals. With
neutrophil and platelet numbers of this magnitude the dog was no longer at significant
risk for acquiring secondary infections or for developing spontaneous haemorrhage.
Within two weeks all haematology parameters were within normal reference ranges.
Notably, the neutrophil count was (6.75 x 109/l, ref 3.6-12) and platelet (246 x 109/l, ref
200-500). Antibiotic therapy was withdrawn once the neutrophil count was within the
reference range. The absence of underlying infectious, neoplastic and autoimmune
disorders together with resolution of clinical signs and pancytopenia upon cessation of
febendazole therapy was highly suggestive of bone marrow hypoplasia associated with
febendazole administration in this case.
The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336.
www.ed.ac.uk/vet/hfsa-int-med
page 3 of 3
Acute Toxic Insult to the Bone Marrow
of 3
Report
Tell us what’s wrong with it:
Thanks, got it!
We will moderate it soon!
Struggling with your assignment and deadlines?
Let EduBirdie's experts assist you 24/7! Simply submit a form and tell us what you need help with.